Germany’s Covid-19 vaccination timetable was thrown into disarray yet again after its vaccine commission recommended a temporary halt on the use of the AstraZeneca vaccine in people below 60 years of age. A survey last week suggested that nearly a quarter of Germans would be wary of accepting the AstraZeneca jab. Earlier this month many EU countries suspended the use of the vaccine in elderly people but resumed after further clarification by the EU regulator. The Danish Medicines Agency said last Thursday it “can’t be ruled out that there is a connection between the vaccine and the very rare blood clot cases”. BioNTech said it expects €9.8 billion in revenue from the supply contracts signed already, which amount to 1.4 billion doses.

Source: The Irish Times March 30, 2021 14:01 UTC